{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:42:31Z","timestamp":1790145751056,"version":"4.0.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Otitis media in young children is associated with major resource use including antimicrobial consumption and tympanostomy tube placements (TTPs). We evaluated the impact of 10-valent pneumococcal conjugate vaccine (PCV10) introduction into the Finnish National Vaccination Programme (NVP) against these outcomes in vaccine-eligible children.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>PCV10-NVP began September 2010 with a 2\u2009+\u20091 schedule; uptake in 2012 was estimated at 92%. The relative and absolute reduction in the NVP-eligible target cohort was compared with a season and age-matched (3\u201354 months) cohort before NVP introduction. Outpatient antimicrobial purchase data were collected from the Social Insurance Institution register. Data on purchases of antimicrobials recommended for treatment of acute otitis media by the Finnish Current Care Guidelines (amoxicillin with\/without enzyme inhibitor, cefuroxime, cefaclor, clarithromycin, azithromycin) were collected, but full data on penicillin and sulfadiazine\/trimethoprim were not available. Data on all TTP procedures were obtained from national hospital discharge register and Social Insurance Institution benefits register. Generalized Cox regression was used in the analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The incidence rates of antimicrobial purchases in the reference and target cohorts were 1.09 and 0.89 per person-year, respectively. The relative rate reduction was 17.5% (95% confidence interval: 17.0\u201318.1) and the absolute rate reduction 0.20 per person-year. The rates of TTP in the reference and target cohorts were 5.41\/100 and 4.56\/100 person-years, respectively. The relative rate reduction was 14.8% (95% confidence interval: 13.1\u201316.5) and the absolute rate reduction 0.86\/100 person-years.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Use of antimicrobials and TTPs reduced after PCV10 was introduced into a routine vaccination program. This suggests considerable savings in health care resource use.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000001810","type":"journal-article","created":{"date-parts":[[2017,10,31]],"date-time":"2017-10-31T16:24:09Z","timestamp":1509467049000},"page":"97-102","source":"Crossref","is-referenced-by-count":33,"title":["Impact of National Ten-Valent Pneumococcal Conjugate Vaccine Program on Reducing Antimicrobial Use and Tympanostomy Tube Placements in Finland"],"prefix":"10.1097","volume":"37","author":[{"given":"Arto A.","family":"Palmu","sequence":"first","affiliation":[{"name":"Department of Epidemiology, School of Health Sciences, University of Tampere, Tampere, Finland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Rinta-Kokko","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, School of Health Sciences, University of Tampere, Tampere, Finland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Nohynek","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, School of Health Sciences, University of Tampere, Tampere, Finland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Pekka","family":"Nuorti","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, School of Health Sciences, University of Tampere, Tampere, Finland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"Jokinen","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, School of Health Sciences, University of Tampere, Tampere, Finland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230913","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/00365540801938931","article-title":"Trends and geographical variation in invasive pneumococcal infections in Finland.","volume":"40","author":"Klemets","year":"2008","journal-title":"Scand J Infect Dis"},{"key":"R2-20230913","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/00006454-200107000-00004","article-title":"Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life.","volume":"20","author":"Kilpi","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R3-20230913","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media.","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"key":"R4-20230913","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/jama.2009.1163","article-title":"Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings.","volume":"302","author":"Grijalva","year":"2009","journal-title":"JAMA"},{"key":"R5-20230913","first-page":"1","article-title":"Ambulatory surgery in the United States, 2006.","volume":"11","author":"Cullen","year":"2009","journal-title":"Natl Health Stat Report"},{"key":"R6-20230913","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00006454-200301000-00006","article-title":"Impact of the pneumococcal conjugate vaccine on otitis media.","volume":"22","author":"Fireman","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R7-20230913","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","article-title":"Pneumococcal capsular polysaccharides conjugated to protein D provide protection against otitis media caused by both Streptococcus pneumoniae and nontypable Haemophilus influenzae: a randomized double blind efficacy study.","volume":"367","author":"Prymula","year":"2006","journal-title":"Lancet"},{"key":"R8-20230913","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1473-3099(13)70338-4","article-title":"Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3-4 trial.","volume":"14","author":"Palmu","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"R9-20230913","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1097\/INF.0000000000000857","article-title":"Effectiveness of the ten-valent pneumococcal conjugate vaccine against tympanostomy tube placements in a cluster-randomized trial.","volume":"34","author":"Palmu","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"R11-20230913","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0140-6736(12)61854-6","article-title":"Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial.","volume":"381","author":"Palmu","year":"2013","journal-title":"Lancet"},{"key":"R14-20230913","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1214\/aos\/1176345976","article-title":"Cox\u2019s regression model for counting processes: a large sample study.","volume":"10","author":"Andersen","year":"1982","journal-title":"Ann Stat"},{"key":"R15-20230913","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1080\/01621459.1989.10478873","article-title":"Regression analysis of multivariate incomplete failure time data by modeling marginal distributions.","volume":"84","author":"Wei","year":"1989","journal-title":"J Am Stat Assoc"},{"key":"R16-20230913","first-page":"1075","article-title":"The robust inference for the Cox proportional hazards model.","volume":"82","author":"Lin","year":"1989","journal-title":"J Am Stat Assoc"},{"key":"R17-20230913","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1542\/peds.2006-0492","article-title":"National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States.","volume":"118","author":"Grijalva","year":"2006","journal-title":"Pediatrics"},{"key":"R18-20230913","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/01.inf.0000133049.30299.5d","article-title":"The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children.","volume":"23","author":"Palmu","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R19-20230913","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/INF.0b013e31827c9bcc","article-title":"Long-term effect of pneumococcal conjugate vaccines on tympanostomy tube placements.","volume":"32","author":"Sarasoja","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R20-20230913","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1542\/peds.2006-2138","article-title":"Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine.","volume":"119","author":"Poehling","year":"2007","journal-title":"Pediatrics"},{"key":"R21-20230913","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/INF.0b013e31819e9bc5","article-title":"The impact of pneumococcal conjugate vaccine on rates of myringotomy with ventilation tube insertion in Australia.","volume":"28","author":"Jardine","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R22-20230913","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jamapediatrics.2013.3924","article-title":"Trends in otitis media-related health care use in the United States, 2001-2011.","volume":"168","author":"Marom","year":"2014","journal-title":"JAMA Pediatr"},{"key":"R23-20230913","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.1016\/j.vaccine.2015.08.022","article-title":"Impact of pneumococcal conjugate vaccines on childhood otitis media in the United Kingdom.","volume":"33","author":"Lau","year":"2015","journal-title":"Vaccine"},{"key":"R24-20230913","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/INF.0000000000000899","article-title":"Decreased incidence of respiratory infections in children after vaccination with ten-valent pneumococcal vaccine.","volume":"34","author":"Sigurdsson","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"R25-20230913","doi-asserted-by":"crossref","first-page":"pii:20948","DOI":"10.2807\/1560-7917.ES2014.19.44.20948","article-title":"Did introduction of pneumococcal vaccines in the Netherlands decrease the need for respiratory antibiotics in children? Analysis of 2002 to 2013 data.","volume":"19","author":"Gefenaite","year":"2014","journal-title":"Euro Surveill"},{"issue":"36","key":"R26-20230913","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/INF.0000000000001705","article-title":"Direct and indirect effectiveness of the 10-valent pneumococcal conjugate vaccine against carriage in a cluster randomized trial.","author":"Palmu","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"R28-20230913","first-page":"2129","article-title":"\u00c4killinen v\u00e4likorvatulehdus.","volume":"120","year":"2004","journal-title":"Duodecim"},{"key":"R30-20230913","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1086\/383309","article-title":"Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001.","volume":"38","author":"Bergman","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R32-20230913","doi-asserted-by":"crossref","first-page":"e0120290","DOI":"10.1371\/journal.pone.0120290","article-title":"Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children \u2013 a population-based cohort study.","volume":"10","author":"Jokinen","year":"2015","journal-title":"Plos One"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201801000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T18:15:13Z","timestamp":1694628913000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201801000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001810","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}